These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9194954)

  • 21. [Cerebrospinal fluid proteins in the diagnosis of disorders of the blood-cerebrospinal fluid barrier in central nervous system diseases].
    Turecký L; Kalina P; Uhlíková E; Procházková L
    Bratisl Lek Listy; 1998 Jul; 99(7):347-50. PubMed ID: 9748723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.
    Liguori C; Romigi A; Nuccetelli M; Zannino S; Sancesario G; Martorana A; Albanese M; Mercuri NB; Izzi F; Bernardini S; Nitti A; Sancesario GM; Sica F; Marciani MG; Placidi F
    JAMA Neurol; 2014 Dec; 71(12):1498-505. PubMed ID: 25322206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between cerebrospinal fluid biomarkers and depression in elderly women.
    Gudmundsson P; Skoog I; Waern M; Blennow K; Pálsson S; Rosengren L; Gustafson D
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):832-8. PubMed ID: 17911361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid 'neuronal thread protein' comes from serum by passage over the blood-brain barrier.
    Blennow K; Wallin A; Chong JK
    Neurodegeneration; 1995 Jun; 4(2):187-93. PubMed ID: 7583683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors.
    Blennow K; Wallin A; Fredman P; Karlsson I; Gottfries CG; Svennerholm L
    Acta Neurol Scand; 1990 Apr; 81(4):323-6. PubMed ID: 2360400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
    J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias.
    Busse M; Kunschmann R; Dobrowolny H; Hoffmann J; Bogerts B; Steiner J; Frodl T; Busse S
    Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):483-492. PubMed ID: 28176002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signs of impaired blood-brain barrier function and lower IgG synthesis within the central nervous system in patients with schizophrenia or related psychosis, compared to that in controls.
    Melkersson K; Bensing S
    Neuro Endocrinol Lett; 2018 Mar; 39(1):33-42. PubMed ID: 29803205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia.
    Schwarz MJ; Ackenheil M; Riedel M; Müller N
    Neurosci Lett; 1998 Sep; 253(3):201-3. PubMed ID: 9792246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.
    Reiber H
    J Neurol Sci; 1994 Apr; 122(2):189-203. PubMed ID: 8021703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.
    Johansson P; Åberg D; Johansson JO; Mattsson N; Hansson O; Ahrén B; Isgaard J; Åberg ND; Blennow K; Zetterberg H; Wallin A; Svensson J
    Psychoneuroendocrinology; 2013 Sep; 38(9):1729-37. PubMed ID: 23473966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
    Andreasen N; Hesse C; Davidsson P; Minthon L; Wallin A; Winblad B; Vanderstichele H; Vanmechelen E; Blennow K
    Arch Neurol; 1999 Jun; 56(6):673-80. PubMed ID: 10369305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid proteins in patients with leucoaraiosis: possible abnormalities in blood-brain barrier function.
    Pantoni L; Inzitari D; Pracucci G; Lolli F; Giordano G; Bracco L; Amaducci L
    J Neurol Sci; 1993 Apr; 115(2):125-31. PubMed ID: 8482973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.
    Sanfilippo C; Forlenza O; Zetterberg H; Blennow K
    J Neural Transm (Vienna); 2016 Dec; 123(12):1443-1447. PubMed ID: 27531278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depression subtypes and 5-year risk of dementia and Alzheimer disease in patients aged 70 years.
    Vilalta-Franch J; López-Pousa S; Llinàs-Reglà J; Calvó-Perxas L; Merino-Aguado J; Garre-Olmo J
    Int J Geriatr Psychiatry; 2013 Apr; 28(4):341-50. PubMed ID: 22588687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction.
    Winfield JB; Shaw M; Silverman LM; Eisenberg RA; Wilson HA; Koffler D
    Am J Med; 1983 May; 74(5):837-44. PubMed ID: 6837607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
    Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression.
    Hesse R; Lausser L; Gummert P; Schmid F; Wahler A; Schnack C; Kroker KS; Otto M; Tumani H; Kestler HA; Rosenbrock H; von Arnim CA
    Alzheimers Res Ther; 2017 Mar; 9(1):17. PubMed ID: 28274265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease.
    Licastro F; Parnetti L; Morini MC; Davis LJ; Cucinotta D; Gaiti A; Senin U
    Alzheimer Dis Assoc Disord; 1995; 9(2):112-8. PubMed ID: 7662323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.